Open access
Sep 2026
Ferroptosis regulates metabolic inflammation-driven tumorigenesis in obesity-related gastric cancer.
Cotreatment with HFD and GSK may promote SCJ tumor progression by suppressing ferroptosis through intratumoral NRF2 signaling and dysbiosis-related metabolites, indicating a negative role of PPAR-δ signaling on MetS-related SCJ tumorigenesis.
Mizuki Tanabe, K. Uno, Toru Tamahara et al.
· Cellular and Molecular Gastr... · 0 citations